{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:43:46Z","timestamp":1788435826191,"version":"build-2803163510"},"reference-count":55,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2021,12,19]],"date-time":"2021-12-19T00:00:00Z","timestamp":1639872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Coronavirus disease 2019 (COVID-19) vaccines can cause transient local and systemic post-vaccination reactions. The aim of this study was to report uveitis and other ocular complications following COVID-19 vaccination. The study included 42 eyes of 34 patients (20 females, 14 males), with a mean age of 49.8 years (range 18\u201383 years). The cases reported were three herpetic keratitis, two anterior scleritis, five anterior uveitis (AU), three toxoplasma retinochoroiditis, two Vogt-Koyanagi-Harada (VKH) disease reactivations, two pars planitis, two retinal vasculitis, one bilateral panuveitis in new-onset Beh\u00e7et\u2019s disease, three multiple evanescent white dot syndromes (MEWDS), one acute macular neuroretinopathy (AMN), five retinal vein occlusions (RVO), one non-arteritic ischemic optic neuropathy (NAION), three activations of quiescent choroidal neovascularization (CNV) secondary to myopia or uveitis, and one central serous chorioretinopathy (CSCR). Mean time between vaccination and ocular complication onset was 9.4 days (range 1\u201330 days). Twenty-three cases occurred after Pfizer-BioNTech vaccination (BNT162b2 mRNA), 7 after Oxford-AstraZeneca vaccine (ChAdOx1 nCoV-19), 3 after ModernaTX vaccination (mRNA-1273), and 1 after Janssen Johnson &amp; Johnson vaccine (Ad26.COV2). Uveitis and other ocular complications may develop after the administration of COVID-19 vaccine.<\/jats:p>","DOI":"10.3390\/jcm10245960","type":"journal-article","created":{"date-parts":[[2021,12,19]],"date-time":"2021-12-19T20:37:27Z","timestamp":1639946247000},"page":"5960","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["Uveitis and Other Ocular Complications Following COVID-19 Vaccination"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0292-0153","authenticated-orcid":false,"given":"Elena","family":"Bolletta","sequence":"first","affiliation":[{"name":"Ocular Immunology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Iannetta","sequence":"additional","affiliation":[{"name":"Ophthalmology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Mastrofilippo","sequence":"additional","affiliation":[{"name":"Ocular Immunology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1471-1914","authenticated-orcid":false,"given":"Luca","family":"De Simone","sequence":"additional","affiliation":[{"name":"Ocular Immunology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4147-5534","authenticated-orcid":false,"given":"Fabrizio","family":"Gozzi","sequence":"additional","affiliation":[{"name":"Ocular Immunology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8622-0439","authenticated-orcid":false,"given":"Stefania","family":"Croci","sequence":"additional","affiliation":[{"name":"Clinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6830-6781","authenticated-orcid":false,"given":"Martina","family":"Bonacini","sequence":"additional","affiliation":[{"name":"Clinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Belloni","sequence":"additional","affiliation":[{"name":"Clinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Zerbini","sequence":"additional","affiliation":[{"name":"Clinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2477-5463","authenticated-orcid":false,"given":"Chantal","family":"Adani","sequence":"additional","affiliation":[{"name":"Ocular Immunology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3877-0417","authenticated-orcid":false,"given":"Luigi","family":"Fontana","sequence":"additional","affiliation":[{"name":"Ophthalmology Unit, DIMES, Alma Mater Studiorum, University of Bologna, S. Orsola-Malpighi Teaching Hospital, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Salvarani","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy"},{"name":"Department of Surgery, Medicine, Dentistry and Morphological Sciences, with Interest in Transplants, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, 41124 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7956-9950","authenticated-orcid":false,"given":"Luca","family":"Cimino","sequence":"additional","affiliation":[{"name":"Ocular Immunology Unit, Azienda USL-IRCCS, 42123 Reggio Emilia, Italy"},{"name":"Department of Surgery, Medicine, Dentistry and Morphological Sciences, with Interest in Transplants, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, 41124 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.abc1932","article-title":"Development of an inactivated vaccine candidate for SARS-CoV-2","volume":"369","author":"Gao","year":"2020","journal-title":"Science"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1473-3099(20)30831-8","article-title":"Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: A randomised, double-blind, placebo-controlled, phase 1\/2 trial","volume":"31","author":"Xia","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against COVID-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1056\/NEJMoa2107659","article-title":"Safety and Efficacy of NVX-CoV2373 COVID-19 Vaccine","volume":"385","author":"Heath","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaad.2021.03.092","article-title":"Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases","volume":"85","author":"McMahon","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Ng, X.L., Betzler, B.K., Testi, I., Ho, S.L., Tien, M., Ngo, W.K., Zierhut, M., Chee, S.P., Gupta, V., and Pavesio, C.E. (2021). Ocular Adverse Events After COVID-19 Vaccination. Ocul. Immunol. Inflamm., 1\u20139.","DOI":"10.1080\/09273948.2021.1976221"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"The Standardization of Uveitis Nomenclature (SUN) Working Group (2005). Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am. J. Ophthalmol., 140, 509\u2013516.","DOI":"10.1016\/j.ajo.2005.03.057"},{"key":"ref_11","first-page":"48","article-title":"Vaccine-Associated Uveitis. 2016","volume":"113","author":"Benage","year":"2016","journal-title":"Mo Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/ICU.0000000000000530","article-title":"Drug-induced uveitis","volume":"29","author":"Moorthy","year":"2018","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/09273948.2019.1626188","article-title":"Vaccine-Associated Uveitis","volume":"27","author":"Cunningham","year":"2019","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_14","first-page":"595","article-title":"Vaccine-Associated Posterior Uveitis","volume":"40","author":"Cunningham","year":"2020","journal-title":"Retin. Cases Brief Rep."},{"key":"ref_15","unstructured":"Cheng, J.Y., and Margo, C.E. (2021). Ocular adverse events following vaccination: Overview and update. Surv. Ophthalmol., in press."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/jamaophthalmol.2021.3477","article-title":"Association of Ocular Adverse Events With Inactivated COVID-19 Vaccination in Patients in Abu Dhabi","volume":"139","author":"Pichi","year":"2021","journal-title":"JAMA Ophthalmol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1097\/IAE.0000000000003277","article-title":"Uveitis following the BNT162b2 mRNA vaccination against SARS-CoV-2 infection","volume":"41","author":"Rabinovitch","year":"2021","journal-title":"Retina"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/09273948.2021.1957123","article-title":"Bilateral Multifocal Choroiditis following COVID-19 Vaccination","volume":"29","author":"Goyal","year":"2021","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Mungmunpuntipantip, R., and Wiwanitkit, V. (2021). COVID-19 Vaccination and Bilateral Multifocal Choroiditis. Ocul. Immunol. Inflamm.","DOI":"10.1080\/09273948.2021.1968003"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/j.jaad.2020.06.063","article-title":"Comment on: \u201cTo consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out. Characterization of herpetic lesions in hospitalized COVID-19 patients\u201d","volume":"83","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.1002\/jmv.27036","article-title":"Herpes zoster emergence following mRNA COVID-19 vaccine","volume":"93","author":"Eid","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jdcr.2021.04.014","article-title":"Varicella-zoster virus reactivation after SARS-CoV-2 BNT162b2 mRNA vaccination: Report of 5 cases","volume":"12","author":"Chicharro","year":"2021","journal-title":"JAAD Case Reports"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/jocd.14035","article-title":"Herpes zoster following inactivated COVID-19 vaccine: A coexistence or coincidence?","volume":"20","author":"Bostan","year":"2021","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12348-021-00260-4","article-title":"Varicella-zoster virus reactivation causing herpes zoster ophthalmicus ( HZO ) after SARS-CoV-2 vaccination\u2013report of three cases","volume":"11","author":"Papasavvas","year":"2021","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Triantafyllidis, K.K., Giannos, P., Mian, I.T., Kyrtsonis, G., and Kechagias, K.S. (2021). Varicella zoster virus reactivation following COVID-19 vaccination: A systematic review of case reports. Vaccines, 9.","DOI":"10.3390\/vaccines9091013"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/ijd.15001","article-title":"Herpes zoster in COVID-19-positive patients","volume":"59","author":"Tartari","year":"2020","journal-title":"Int. J. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12348-021-00262-2","article-title":"Effect of SARS-CoV-2 mRNA vaccination on ocular herpes simplex and varicella-zoster virus reactivation : Should preventive antiviral treatment be given in known herpes patients. Ocul Immunol Inflamm","volume":"11","author":"Herbort","year":"2021","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"ref_28","first-page":"e1056","article-title":"Episcleritis as an ocular manifestation in a patient with COVID-19","volume":"98","author":"Barraquer","year":"2020","journal-title":"Acta Ophthalmol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s00417-020-04777-7","article-title":"Ocular manifestations of coronavirus disease","volume":"258","author":"Ozates","year":"2020","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12519-021-00418-z","article-title":"COVID-19 ocular findings in children: A case series","volume":"17","year":"2021","journal-title":"World J. Pediatr. Springer Singapore"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/ICO.0000000000002795","article-title":"Anterior Scleritis Manifesting After Coronavirus Disease 2019: A Report of Two Cases","volume":"40","author":"Feizi","year":"2021","journal-title":"Cornea"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijid.2021.07.035","article-title":"Anterior uveitis onset after bnt162b2 vaccination: Is this just a coincidence?","volume":"110","author":"Renisi","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciimmunol.abj9256","article-title":"COVID-19 vaccine side effects: The positives about feeling bad","volume":"6","author":"Sprent","year":"2021","journal-title":"Sci. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s40588-019-0114-5","article-title":"Toxoplasma: Immunity and Pathogenesis","volume":"6","author":"Khan","year":"2019","journal-title":"Curr. Clin. Microbiol. Reports"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12348-021-00251-5","article-title":"Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination","volume":"11","author":"Papasavvas","year":"2021","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Erdem, S., Karahan, M., Dursun, M.E., Ava, S., Hazar, L., Katran, I., and Keklikci, U. (2021). Retinal Vasculitis Case Developing in the Early Period after COVID-19. Klin. Monbl. Augenheilkd.","DOI":"10.1055\/a-1363-1326"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Insausti-Garc\u00eda, A., Reche-Sainz, J.A., Ruiz-Arranz, C., L\u00f3pez V\u00e1zquez, \u00c1., and Ferro-Osuna, M. (2020). Papillophlebitis in a COVID-19 patient: Inflammation and hypercoagulable state. Eur. J. Ophthalmol.","DOI":"10.1177\/1120672120947591"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Tagini, F., Carrel, L., Fallet, B., Gachoud, D., Ribi, C., and Monti, M. (2021). Beh\u00e7et\u2019s-like adverse event or inaugural Beh\u00e7et\u2019s disease after SARS-CoV-2 mRNA-1273 vaccination?. Rheumatology, 3\u20137.","DOI":"10.1093\/rheumatology\/keab751"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1038\/s41433-020-1069-8","article-title":"Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection","volume":"34","author":"Virgo","year":"2020","journal-title":"Eye"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"B\u00f8hler, A.D., Str\u00f8m, M.E., Sandvig, K.U., Moe, M.C., and J\u00f8rstad, \u00d8.K. (2021). Acute macular neuroretinopathy following COVID-19 vaccination. Eye, 1\u20132.","DOI":"10.1038\/s41433-021-01610-1"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e212471","DOI":"10.1001\/jamaophthalmol.2021.2471","article-title":"Bilateral Acute Macular Neuroretinopathy after Vaccination against SARS-CoV-19","volume":"139","author":"Book","year":"2021","journal-title":"JAMA Ophthalmol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1080\/09273948.2021.1946567","article-title":"Acute Macular Neuroretinopathy following Coronavirus Disease 2019 Vaccination","volume":"29","author":"Mambretti","year":"2021","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Michel, T., Stolowy, N., Gascon, P., Dupessey, F., Comet, A., Attia, R., David, T., and Denis, D. (2021). Acute Macular Neuroretinopathy After COVID-19 Vaccine. J Ophthal Inflamm Infect., 1\u20139.","DOI":"10.21203\/rs.3.rs-632137\/v1"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.4103\/ijo.IJO_2380_20","article-title":"Retinal vein occlusion in COVID-19: A novel entity","volume":"68","author":"Sheth","year":"2020","journal-title":"Indian J. Ophthalmol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"488","DOI":"10.4103\/ijo.IJO_297_21","article-title":"COVID-19 and eye: A review of ophthalmic manifestations of COVID-19","volume":"69","author":"Sen","year":"2021","journal-title":"Indian J. Ophthalmol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e425","DOI":"10.1016\/S2352-3026(20)30151-4","article-title":"COVID-19 coagulopathy: An evolving story","volume":"7","author":"Haematology","year":"2020","journal-title":"Lancet Haematol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S0140-6736(21)00872-2","article-title":"Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"397","author":"Bayas","year":"2021","journal-title":"Lancet"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e2021048","DOI":"10.4084\/MJHID.2021.048","article-title":"A rare case of superior ophthalmic vein thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccine against SARS-CoV-19","volume":"13","author":"Trajkova","year":"2021","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1007\/s10792-021-01971-2","article-title":"Central retinal vein occlusion occurring immediately after 2nd dose of mRNA SARS-CoV-2 vaccine","volume":"41","author":"Bialasiewicz","year":"2021","journal-title":"Int. Ophthalmol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.4103\/ijo.IJO_1477_21","article-title":"Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination: A case report","volume":"69","author":"Endo","year":"2021","journal-title":"Indian J. Ophthalmol."},{"key":"ref_51","first-page":"10","article-title":"A Case of Non-Arteritic Anterior Ischemic Optic Neuropathy with COVID-19","volume":"12","author":"Rho","year":"2020","journal-title":"Cureus"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bcr-2020-240542","article-title":"Non-arteritic anterior ischaemic optic neuropathy sequential to SARS-CoV-2 virus pneumonia: Preventable by endothelial protection?","volume":"14","author":"Moschetta","year":"2021","journal-title":"BMJ Case Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12886-021-02028-9","article-title":"Proning related bilateral anterior ischaemic optic neuropathy in a patient with COVID-19 related acute respiratory distress syndrome","volume":"21","author":"Clarke","year":"2021","journal-title":"BMC Ophthalmol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Girbardt, C., Busch, C., Al-Sheikh, M., Gunzinger, J.M., Invernizzi, A., Xhepa, A., Unterlauft, J.D., and Rehak, M. (2021). Retinal Vascular Events after mRNA and Adenoviral-Vectored COVID-19 Vaccines\u2014A Case Series. Vaccines, 9.","DOI":"10.3390\/vaccines9111349"},{"key":"ref_55","first-page":"101136","article-title":"Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine","volume":"23","author":"Fowler","year":"2021","journal-title":"Am. J. Ophthalmol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/24\/5960\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:51:47Z","timestamp":1760169107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/24\/5960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,19]]},"references-count":55,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["jcm10245960"],"URL":"https:\/\/doi.org\/10.3390\/jcm10245960","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,19]]}}}